2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management.
about
Ventricular pacing - Electromechanical consequences and valvular functionAppropriateness criteria for cardiovascular imaging use in heart failure: report of literature reviewDevelopments in Cardiac Resynchronisation Therapy.Risk-benefit assessment of ivabradine in the treatment of chronic heart failureNew devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association.Device therapies: new indications and future directions.Feasibility of a novel atrioventricular delay optimization method using transmitral and pulmonary venous flow in patients with sequential ventricular pacing or cardiac resynchronization therapy.Evidence that conflict regarding size of haemodynamic response to interventricular delay optimization of cardiac resynchronization therapy may arise from differences in how atrioventricular delay is kept constantA Critical Reappraisal of the Current Clinical Indications to Cardiac Resynchronisation Therapy.The ratio of the neutrophil leucocytes to the lymphocytes predicts the outcome after cardiac resynchronization therapy.An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure.Cost-Effectiveness Analysis of Quadripolar Versus Bipolar Left Ventricular Leads for Cardiac Resynchronization Defibrillator Therapy in a Large, Multicenter UK Registry.The Year in Cardiology 2012: arrhythmia and pacing.The high-risk patient with heart failure with reduced ejection fraction: treatment options and challenges.New developments in the delivery of cardiac resynchronization therapy: targeted lead placement, multi-site and endocardial pacing.Cardiac resynchronization therapy: the state of the art.Strategies to improve cardiac resynchronization therapy.Coronary venous system in cardiac computer tomography: Visualization, classification and role.Management of antithrombotic therapy in patients undergoing electrophysiological device surgery.Delayed AICD therapy and cardiac arrest resulting from undersensing of ventricular fibrillation in a subject with hypertrophic cardiomyopathy-A case report.Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis.A comparison of the different features of quadripolar left ventricular pacing leads to deliver cardiac resynchronization therapy.Comprehensive use of cardiac computed tomography to guide left ventricular lead placement in cardiac resynchronization therapy.An updated review of cardiac devices in heart failure.Cardiac resynchronization therapy for patients with cardiac sarcoidosis.Avoiding non-responders to cardiac resynchronization therapy: a practical guide.The importance of myocardial contractile reserve in predicting response to cardiac resynchronization therapy.What is the cost of non-response to cardiac resynchronization therapy? Hospitalizations and healthcare utilization in the CRT-D population.Using three-dimensional echocardiography to guide left ventricle lead position in cardiac resynchronization therapy: does it make any difference.Cardiac resynchronization therapy (CRT) device replacement considerations: upgrade or downgrade? A complex decision in the current clinical setting.Optimization of heart failure medication after cardiac resynchronization therapy and the impact on long-term survival.T-wave area as biomarker of clinical response to cardiac resynchronization therapy.Do cardiologists follow the European guidelines for cardiac pacing and resynchronization therapy? Results of the European Heart Rhythm Association survey.Cardiac resynchronization therapy device implantation guided by electroanatomic mapping system when contrast medium infusion is contraindicated.For LV pacing, four is greater than twoComparison of strain parameters in dyssynchronous heart failure between speckle tracking echocardiography vendor systems.A comparison between radial strain evaluation by speckle-tracking echocardiography and cardiac magnetic resonance imaging, for assessment of suitable segments for left ventricular lead placement in cardiac resynchronization therapy.Effects of smoking in patients treated with cardiac resynchronization therapy.Clinical response with adaptive CRT algorithm compared with CRT with echocardiography-optimized atrioventricular delay: a retrospective analysis of multicentre trials.[The chronic critically ill patient from the cardiologist's perspective].
P2860
Q26739896-D73DA237-B2CC-4455-9400-9862886B6EE5Q26992237-B285E846-A18B-497B-A29C-196DDA217CCBQ30392124-193913A4-3505-46CB-A7E3-2FBC8E2E5122Q33568592-395D1951-0CC4-4FBD-A020-16D304EE6C97Q34387086-8F36E21B-01BC-4D97-AE3B-A14894C0D5B6Q35139951-F838DE8F-1ADD-4DA4-B980-A886FC3176AEQ35680955-43797ADD-8621-475D-ACEC-18617BC46B63Q36428817-F30F5D4F-D756-4FCC-9FF3-ADB794BB1D11Q36458915-059C0622-1FB2-4782-947B-4D8A8457BFFDQ36935337-1EB24574-4F8A-4BBD-A046-6FE6DACCA9A0Q37374291-EEFE1A37-20AE-403E-AC1F-96891B076B66Q37669398-22004CA6-FFC6-4D0B-AEF3-BE772EEA9D63Q38071285-29C28CD3-3CA8-43DB-88DD-1986A8446B8BQ38121483-5E863B81-9F78-4EB5-82D6-CE92029B30CFQ38193575-647C3362-D63F-41F3-85E0-C0B518A4A702Q38205885-01E870AA-99C8-485F-8950-0EEA86CCE4D0Q38212706-2AFE4034-2708-4658-BDCA-315436DF1410Q38234979-4F5AD786-71A7-4CB0-B87C-75B085577C9CQ38364982-C39129F7-5572-4E52-8737-09044874ADD5Q38365232-08E48368-3F20-4A31-B072-641B7F2CA997Q38450566-F7A6E392-E1CD-430D-AF8C-AC3AA0C9B835Q38638039-38F27168-B51E-4A8A-BD61-4DE1A0945EC7Q38799475-C8AC7A75-2A2E-494D-AC11-C94622063C48Q38876024-E4E4C337-37A1-4F02-B8B7-E4D0303C7243Q38878994-1798FF38-3725-482E-9FDC-A3B01D5F68ECQ38884026-64A931B2-84A0-44FD-BBE5-12EBFC129441Q38944610-DA43AF91-2756-41EA-AFC8-315FCF0A83AEQ38950580-FBD4AA74-5305-4084-ABB5-C9B87AB34B1AQ38962952-BB95EB62-633B-4AC1-97F5-1E1F7158EFA6Q39052134-6AE57ECE-B977-4868-9808-D149226BB5D9Q39481491-02252758-A489-4DD0-9E56-11A0FB5FBEC5Q41227451-2B25262E-7FBA-441D-AA15-7F654BF8B00DQ41634335-BFA656AD-C81C-4632-9769-A2CB0D124496Q42175080-7F4E26D1-B12B-4E3A-AEBE-AA1219A3FE31Q42315407-8F5B95F6-FF8A-4A83-AB08-5AC18F626FD3Q42672487-907B4ABB-F09A-479A-A495-C5D2A53D10E3Q43483584-FE1A599F-EAD7-4486-B1A7-F553F84446F8Q43735709-CDC12332-FF05-4C2D-AB84-57926E5747B8Q43977545-2695FCF8-DD90-4C4D-81A5-12B5E0ACCB8EQ44604453-2860F2F0-1868-460D-A95F-5CD50C34D74D
P2860
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
2012 EHRA/HRS expert consensus ...... ecommendations and management.
@en
type
label
2012 EHRA/HRS expert consensus ...... ecommendations and management.
@en
prefLabel
2012 EHRA/HRS expert consensus ...... ecommendations and management.
@en
P2093
P2860
P50
P356
P1433
P1476
2012 EHRA/HRS expert consensus ...... ecommendations and management.
@en
P2093
American Heart Association (AHA)
American Society of Echocardiography (ASE)
Anthony S Tang
Bela Merkely
Carsten Israel
Christian Tobias Torp-Pedersen
Christophe Leclercq
David B DeLurgio
David Haines
David L Hayes
P2860
P304
P356
10.1093/EUROPACE/EUS222
P50
P577
2012-09-01T00:00:00Z